Organization
Eberhard Karls University of Tuebingen
3 abstracts
Abstract
Efficacy of adjuvant therapy in patients (pts) with AJCC v8 stage IIIA cutaneous melanoma.Org: Melanoma Institute Australia, The Netherlands Cancer Institute, Amsterdam University Medical Centers, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, The Christie NHS Foundation Trust,
Abstract
EGFR expression and relapse in patients with melanoma receiving adjuvant PD-1-based immunotherapy.Org: Skin Cancer Center, University Hospital Leipzig, Department of Dermatology, Eberhard Karls University of Tuebingen, Tübingen, Germany, Kantonsspital St. Gallen,
Abstract
Interim analysis of MelaRisk, a biomarker assay validation study in stage IB/IIA melanoma tissue.Org: Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany, Tübingen, Germany,